Covariate-adaptive randomization represents an advanced methodology in the design of clinical trials, ensuring a balanced distribution of prognostic factors among treatment groups. This approach ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Over the past few years, we’ve seen a wave of digital innovation in clinical trials: ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...